Advate

Playing defense, Baxalta makes its case for a new hemophilia drug
Fierce Biotech
Thu, 07/16/15 - 04:52 pm
Baxalta
hemophilia A
BAX 855
Advate
Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground
Fierce Pharma Marketing
Thu, 11/13/14 - 11:02 am
Biogen Idec
Elocate
Baxter International
Advate
Long-acting version of Baxter's hemophilia drug succeeds in study
Yahoo/Reuters
Thu, 08/21/14 - 11:38 am
Baxter International
Advate
hemophilia A
BAX 855
Positive Data for Baxter's Advate
Yahoo/Zacks
Wed, 07/3/13 - 03:25 pm
Baxter
Advate
data
Baxter loses Medicare hemophilia drug price suit
Yahoo/AP
Fri, 08/14/09 - 04:07 pm
Baxter International
hemophilia
Medicare
Advate